首页> 美国卫生研究院文献>Transactions of the American Ophthalmological Society >In Vitro Studies on the Antimicrobial Peptide Human Beta-Defensin 9 (HBD9): Signalling Pathways and Pathogen-Related Response (An American Ophthalmological Society Thesis)
【2h】

In Vitro Studies on the Antimicrobial Peptide Human Beta-Defensin 9 (HBD9): Signalling Pathways and Pathogen-Related Response (An American Ophthalmological Society Thesis)

机译:体外抗菌肽人β-防御素9(HBD9)的体外研究:信号通路和病原相关反应(美国眼科学会论文)

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Purpose:Human β-defensins (HBDs) are an important part of the innate immune host defense at the ocular surface. Unlike other defensins, expression of HBD9 at the ocular surface is reduced during microbial infection, but activation of toll-like receptor 2 (TLR2) in corneal epithelial cells has been shown to up-regulate HBD9. Our purpose was to test the hypothesis that TLR2 has a key role in the signalling pathway(s) involved in the overexpression or underexpression of HBD9, and accordingly, different pathogens would induce a different expression pattern of HBD9.
机译:目的:人β-防御素(HBD)是眼表先天免疫宿主防御的重要组成部分。与其他防御素不同,在微生物感染过程中,眼表面HBD9的表达降低,但角膜上皮细胞中Toll样受体2(TLR2)的激活已显示出上调HBD9的作用。我们的目的是检验以下假设:TLR2在涉及HBD9过度表达或表达不足的信号传导途径中具有关键作用,因此,不同的病原体会诱导HBD9的不同表达方式。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号